Florida Cancer Specialists & Research Institute, LLC (FCS) has appointed Sachin Kamath, MD as Chairman of the FCS Executive Board Compliance Committee, effective February 16, 2023.
Florida Cancer Specialists & Research Institute, LLC (FCS), a consistent top performer among the 126 U.S.-based oncology practices that participated in the Center for Medicare & Medicaid Innovation (CMMI) Oncology Care Model (OCM), shares its results in the payment and delivery model’s final wave which ended in June 2022 in a newly released case study.
Research conducted through the Florida Cancer Specialists & Research Institute were featured recently at two global gatherings sponsored by the American Society of Clinical Oncology (ASCO®).
Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Hitesh Patel, MD has joined its Executive Board, effective January 27, 2023.
FCS Top News Updates
FCS Leaders Spotlight Innovation and Collaboration at COA 2026 to Advance Community Oncology Care
National Nutrition Month 2023Celebrating National Nutrition Month can be healthful and fun. Here are some ideas from the Academy of Nutrition and Dietetics.
FCS Names Sachin Kamath, MD Compliance Committee ChairmanFlorida Cancer Specialists & Research Institute, LLC (FCS) has appointed Sachin Kamath, MD as Chairman of the FCS Executive Board Compliance Committee, effective February 16, 2023.
FCS a Top Performer in the Center for Medicare & Medicaid Innovation’s Oncology Care ModelFlorida Cancer Specialists & Research Institute, LLC (FCS), a consistent top performer among the 126 U.S.-based oncology practices that participated in the Center for Medicare & Medicaid Innovation (CMMI) Oncology Care Model (OCM), shares its results in the payment and delivery model’s final wave which ended in June 2022 in a newly released case study.
Study shows women with low-risk breast cancer could skip postop radiationA recently published study provides data to support that certain patients can achieve positive outcomes without postoperative radiation.
New Findings in the Diagnosis and Treatment of Gastrointestinal and Genitourinary CancersResearch conducted through the Florida Cancer Specialists & Research Institute were featured recently at two global gatherings sponsored by the American Society of Clinical Oncology (ASCO®).
New Targeted Drug for Patients with Mantle Cell LymphomaFDA approved the first Non-Covalent (Reversible) BTK inhibitor for the treatment of Relapsed or Refractory Mantle Cell Lymphoma in adult patients.
Successful Lifestyle Change: Action & AccountabilityIt’s that time of year again! The time by which 80% of New Year’s Resolutions have failed. What to do if you find yourself in that statistic? Read on!
FCS Appoints Hitesh Patel, MD to Executive BoardFlorida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Hitesh Patel, MD has joined its Executive Board, effective January 27, 2023.